In response to the Centers for Disease Control and Prevention, greater than 37 million people within the U.S. have diabetes. That is a bit of greater than 11% of all the population.
A diabetic’s body doesn’t make enough or any insulin in any respect. Those with the disease must frequently monitor their blood sugar. This has been traditionally done with glucometers, which diabetics use to prick their fingers over and yet again for drops of blood. But during the last decade, technology like continuous glucose monitoring has been on the rise.
Abbott and Dexcom are the 2 most dominant players within the space. Each firms have seen increased growth.
The technology can also be being marketed by several health and wellness apps as many firms see advantages for individuals who haven’t got diabetes.
CNBC spoke with each Abbott and Dexcom in regards to the technology inside continuous glucose monitors and the way they see it expanding.
Watch the video to learn more.